Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
2020年11月19日 - 6:41AM
Edgar (US Regulatory)
Filed by Akers Biosciences, Inc.
Pursuant to Rule 425 of the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
of the Securities Exchange Act of 1934
Subject Company: MyMD Pharmaceuticals, Inc.
Commission File No.: 001-36268
Akers Biosciences (NASDAQ:AKER)
過去 株価チャート
から 6 2024 まで 7 2024
Akers Biosciences (NASDAQ:AKER)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about Akers Biosciences Inc (ナスダック市場): 0 recent articles
その他のAkers Biosciences, Inc.ニュース記事